The FDA refuses to accept the application for the Moderna flu vaccine.

Moderna fell by 11.5% in early trading on Wednesday after the company announced that the FDA had issued a refusal to accept letter for its mRNA flu vaccine application, citing issues with the trial design. The company is seeking an urgent meeting and has already submitted applications in Europe, Canada and Australia.